UPDATE 1-Bristol-Myers buys rights to acquire fibrosis drug developer
August 31, 2015 at 09:39 AM EDT
Aug 31 (Reuters) - Drugmaker Bristol-Myers Squibb said it bought rights to a mid-stage fibrosis drug and its privately held developer for up to $1.25 billion, boosting its pipeline for drugs that treat tissue scarring.
